Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
3.700
-0.050 (-1.33%)
At close: Nov 13, 2026, 4:00 PM EST
3.800
+0.100 (2.70%)
After-hours: Nov 13, 2026, 4:15 PM EST
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $17.78 million as of November 13, 2026. It is the 37,560th most valuable company in the world and the 5,212th biggest in the United States. Its market cap has increased by 75.24% in one year.
Market Cap
17.78M
Enterprise Value
-13.53M
1-Year Change
75.24%
Global Rank
Country Rank
#5,212 United States
Category
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $17.78M, a decrease of -81.71%. That is a compound annual growth rate of -28.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 17.78M | 46.83% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 19.65M |
| Atossa Therapeutics | 19.56M |
| BioStem Technologies | 18.59M |
| IGC Pharma | 18.28M |
| Context Therapeutics | 17.59M |
| Pasithea Therapeutics | 16.71M |
| Bolt Biotherapeutics | 15.85M |
| Akari Therapeutics, | 15.81M |